Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
01-2001 | 10-2000 | 07-2000 | 04-2000 | 01-2000 | |
Cash Flows From Operating Activities | |||||
Net Income | -7,600 | 868,100 | 780,900 | 771,300 | 53,100 |
Depreciation Amortization | 48,300 | 146,200 | 97,400 | 57,700 | 29,600 |
Income taxes - deferred | 1,200 | 332,000 | -2,500 | -1,600 | N/A |
Accounts receivable | 83,300 | -158,700 | -193,000 | -103,200 | 19,100 |
Accounts payable and accrued liabilities | 5,700 | 83,600 | 76,500 | 19,300 | -20,500 |
Other Working Capital | -186,900 | -122,200 | 192,600 | 206,100 | -50,300 |
Other Operating Activity | -37,600 | -898,100 | -890,300 | -916,000 | 2,600 |
Operating Cash Flow | $-93,600 | $250,900 | $61,600 | $33,600 | $33,600 |
Cash Flows From Investing Activities | |||||
PPE Investments | -96,600 | -375,300 | -230,400 | -115,900 | -49,000 |
Net Acquisitions | -48,700 | -345,300 | -314,100 | -56,300 | -18,000 |
Purchase Of Investment | N/A | N/A | N/A | N/A | 23,200 |
Sale Of Investment | -7,800 | 196,500 | 185,200 | 98,000 | 5,400 |
Investing Cash Flow | $-153,100 | $-524,100 | $-359,300 | $-74,200 | $-38,400 |
Cash Flows From Financing Activities | |||||
Debt Issued | 168,600 | -32,500 | N/A | N/A | N/A |
Debt Repayment | N/A | N/A | 32,200 | -23,000 | -26,300 |
Common Stock Issued | 19,000 | 277,200 | 200,700 | 116,900 | 50,700 |
Financing Cash Flow | $187,600 | $244,700 | $232,900 | $93,900 | $24,400 |
Exchange Rate Effect | 100 | -3,700 | -3,100 | -2,200 | -600 |
Beginning Cash Position | 217,300 | 279,000 | 279,000 | 279,000 | 279,000 |
End Cash Position | 158,300 | 217,300 | 211,100 | 330,100 | 298,000 |
Net Cash Flow | $-59,000 | $-61,700 | $-67,900 | $51,100 | $19,000 |
Free Cash Flow | |||||
Operating Cash Flow | -93,600 | 250,900 | 61,600 | 33,600 | 33,600 |
Capital Expenditure | -96,600 | -375,300 | -230,400 | -115,900 | -49,000 |
Free Cash Flow | -190,200 | -124,400 | -168,800 | -82,300 | -15,400 |